EdgarLookup
DEF 14A

DEF 14A Filing

Company
Insight Molecular Diagnostics Inc.
Filed
July 30, 2018
Period of Report
July 27, 2018
Accession Number
0001493152-18-010603

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →